Exact Mass: 456.2445
Exact Mass Matches: 456.2445
Found 272 metabolites which its exact mass value is equals to given mass value 456.2445
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Phytyl diphosphate
Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids. [HMDB]. Phytyl diphosphate is found in many foods, some of which are highbush blueberry, wild leek, evergreen huckleberry, and allium (onion). Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids.
D1927
Lucidenic acid F
Lucidenic acid F is found in mushrooms. Lucidenic acid F is a constituent of Ganoderma lucidum (reishi). Constituent of Ganoderma lucidum (reishi). Lucidenic acid F is found in mushrooms.
Lucidenolactone
Metabolite of Ganoderma lucidum (reishi). Lucidenolactone is found in mushrooms. Lucidenolactone is found in mushrooms. Metabolite of Ganoderma lucidum (reishi
Rigin
Rigin (glycyl-L-glutaminyl-L-prolyl-L-arginine) is a tetrapeptide with functions similar to those of tuftsin. [HMDB] Rigin (glycyl-L-glutaminyl-L-prolyl-L-arginine) is a tetrapeptide with functions similar to those of tuftsin.
N-[(2S)-1-[[(2S)-1-Amino-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide
1-Acetyl-17-(3,3-dimethyloxiranyl)-1,2,3,8a,9,14,15,16a-octahydro-9-methyl-13,16-methano-8H,16H-pyrrolo[2,3:2,3]pyrido[4,3-o]quinindoline
20(21)-Dehydrolucidenic acid A
20(21)-Dehydrolucidenic acid A is a natural product found in Ganoderma sinense and Ganoderma lucidum with data available.
[(3R,4S,8S,8aS)-3-hydroxy-6,8a-dimethyl-8-[(Z)-2-methylbut-2-enoyl]oxy-3-propan-2-yl-1,2,3a,4,5,8-hexahydroazulen-4-yl] 4-hydroxybenzoate
11-O-acetyl-8-epi-torilolone 8-O-beta-D-glucopyranoside
(7R,8R)-7-hydroxy-3-(4-hydroxy-2-methyl-6-oxocyclohexenyl)-7-methyl-8-(3-methyl-2-oxononyl)-7,8-dihydro-isochromene-6-one|cohaerin F
(1S,4R,7S,8aR)-4-((2E,4E)-6,8-dimethyldeca-2,4-dienyloxy)-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,6,7,8,8a-octahydronaphthalene-1-carboxylic acid|07H239-A
8-methoxy-9-hydroxy-3,10-diheptyl-2H,5H-pyran[5,6-c][1]benzopyran-2,5-dione|fordianin B
5,7-dihydroxy-4-(1-hydroxypropyl)-6-(2-methyl-1-oxobutyl)-8-(3,7-dimethyl-2,6-octadienyl)-2H-benzopyran-2-one|kayeassamin C
(-)-5,7-dihydroxy-4-(1S-hydroxypropyl)-6-(3-methyl-1-oxobutyl)-8-(3,7-dimethyl-2,6-octadienyl)-2H-benzopyran-2-one|kayeassamin D
methyl (2beta,12beta,19alpha)-1-[(2E)-3-phenylprop-2-enoyl]aspidospermidin-21-oate|N1-cinnamoyl-12-demethoxycylindrocarine
3-[(2E,6E,10E)-11-carboxy-3,7,15-trimethyl-2,6,10,14-hexadecatetraenyl]-4,5-dihydroxybenzoic acid
9-Hydroxy-gamma-geraniol-1-O-(6-acetyl-3-angelyl)-beta-D-glucopyranoside|9-Hydroxy-gamma-geraniol-1-O-<6-acetyl-3-angelyl>-beta-D-glucopyranoside
Estra-1,3,5(10)-triene-3,16|A,17|A-triol tripropionate
2,6-diheptyl-3,6-dihydroxy-7-methoxy-dibenzofuran-1,4-dione|fordianaquinone B
Lucidenic acid F
Lucidenic acid F is a triterpenoid. Lucidenic acid F is a natural product found in Ganoderma lucidum with data available.
C27H36O6_1-Naphthalenecarboxylic acid, 8-(benzoyloxy)decahydro-7-hydroxy-5-[(3Z)-5-hydroxy-3-methyl-3-penten-1-yl]-1,4a-dimethyl-6-methylene
C27H36O6_Benzoic acid, 4-hydroxy-, (3R,4S,8S,8aS)-1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-8-[[(2Z)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-azulenyl ester
C27H36O6_Benzoic acid, 4-hydroxy-, 1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-8-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-azulenyl ester
Ala Asn Pro Arg
Ala Asn Arg Pro
Ala Pro Asn Arg
Ala Pro Arg Asn
Ala Arg Asn Pro
Ala Arg Pro Asn
Phe Pro Pro Pro
Gly Pro Gln Arg
Gly Pro Arg Gln
Gly Gln Pro Arg
Gly Gln Arg Pro
Gly Arg Pro Gln
Gly Arg Gln Pro
Ile Met Pro Pro
Ile Pro Met Pro
Ile Pro Pro Met
Leu Met Pro Pro
Leu Pro Met Pro
Leu Pro Pro Met
Met Ile Pro Pro
Met Leu Pro Pro
Met Pro Ile Pro
Met Pro Leu Pro
Met Pro Pro Ile
Met Pro Pro Leu
Asn Ala Pro Arg
Asn Ala Arg Pro
Asn Pro Ala Arg
Asn Pro Arg Ala
Asn Arg Ala Pro
Asn Arg Pro Ala
Pro Ala Asn Arg
Pro Ala Arg Asn
Pro Phe Pro Pro
Pro Gly Gln Arg
Pro Gly Arg Gln
Pro Ile Met Pro
Pro Ile Pro Met
Pro Leu Met Pro
Pro Leu Pro Met
Pro Met Ile Pro
Pro Met Leu Pro
Pro Met Pro Ile
Pro Met Pro Leu
Pro Asn Ala Arg
Pro Asn Arg Ala
Pro Pro Phe Pro
Pro Pro Ile Met
Pro Pro Leu Met
Pro Pro Met Ile
Pro Pro Met Leu
Pro Pro Pro Phe
Pro Gln Gly Arg
Pro Gln Arg Gly
Pro Arg Ala Asn
Pro Arg Gly Gln
Pro Arg Asn Ala
Pro Arg Gln Gly
Gln Gly Pro Arg
Gln Gly Arg Pro
Gln Pro Gly Arg
Gln Pro Arg Gly
Gln Arg Gly Pro
Gln Arg Pro Gly
Arg Ala Asn Pro
Arg Ala Pro Asn
Arg Gly Pro Gln
Arg Gly Gln Pro
Arg Asn Ala Pro
Arg Asn Pro Ala
Arg Pro Ala Asn
Arg Pro Gly Gln
Arg Pro Asn Ala
Arg Pro Gln Gly
Arg Gln Gly Pro
Arg Gln Pro Gly
PG(14:0/0:0)[U]
Lucidenolactone
(4S)-3-[(2S,4S)-4-azido-4-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-2-propan-2-ylbutanoyl]-4-benzyl-1,3-oxazolidin-2-one
2,2-[(1-methylethylidene)bis[4,1-phenyleneoxy(1-methyl-2,1-ethanediyl)oxymethylene]]bis-Oxirane
Pipendoxifene
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
N-[1-[(1-amino-1-oxopropan-2-yl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N-hydroxy-2-(2-methylpropyl)butanediamide
1-tetradecanoyl-sn-glycero-3-phospho-(1-sn-glycerol)
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tetradecanoate
Rhodamine B hydrazide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
Xyloketal A
A xyloketal with formula C27H36O6. It was initially isolated from the mangrove fungus Xylaria sp. from the South China sea coast.
Strongylophorine-26
A diterpenoid that is 15,17-epoxypodocarpan-15-one substituted by a hydroxy group at position 13, methyl groups at positions 8 and 13 and a (5-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl)methyl group at position 14 (the 13alpha,14beta stereoisomer). Isolated from the marine sponge Petrosia corticata, it exhibits antineoplastic activity.
2-[4-[2-(3,5-dimethoxyanilino)-2-oxoethyl]-1-piperazinyl]-N-(4-ethoxyphenyl)acetamide
8-benzoyloxy-7-hydroxy-5-[(Z)-5-hydroxy-3-methylpent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid
N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-oxo-1-[(phenylmethyl)amino]propan-2-yl]cyclopropyl]-phenylmethyl]carbamic acid (phenylmethyl) ester
[(1S,5R)-8-methyl-8-[(4-phenylphenyl)methyl]-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
(2S)-N-[3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-2-[[4-(2,5-dioxopyrrolidin-1-yl)-2-sulfanylbutanoyl]amino]-4-methylpentanamide
(5S,12R)-dihydroxy-(6R)-cysteinyl-(7E,9E,14Z)-icosatrienoate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetradecanoate
(E)-3,7,11,15-tetramethylhexadec-2-en-1-yl diphosphate
(12R)-hydroxy-10,11-dihydroleukotriene E4(1-)
An icosanoid anion that is the conjugate base of (12R)-hydroxy-10,11-dihydroleukotriene E4, obtained by deprotonation of the carboxy group; major species at pH 7.3.
TAPI-0
TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM. TAPI-0 is a MMP inhibitor and also attenuates TNF-α processing[1][2].